Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Avax_Technologies> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Avax_Technologies abstract "Avax Technologies, Inc (OTC Pink: AVXT) is a Philadelphia based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007 [1]. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).".
- Avax_Technologies industry Biomedicine.
- Avax_Technologies locationCity Philadelphia.
- Avax_Technologies locationCountry United_States.
- Avax_Technologies service Cancer_vaccine.
- Avax_Technologies type Public_company.
- Avax_Technologies wikiPageExternalLink www.avax-tech.com.
- Avax_Technologies wikiPageExternalLink index.php.
- Avax_Technologies wikiPageExternalLink group.php?v=app_2373072738&ref=mf&gid=254690660179.
- Avax_Technologies wikiPageExternalLink index.htm.
- Avax_Technologies wikiPageID "25516263".
- Avax_Technologies wikiPageRevisionID "575318087".
- Avax_Technologies hasPhotoCollection Avax_Technologies.
- Avax_Technologies headOffice Philadelphia.
- Avax_Technologies homepage www.avax-tech.com.
- Avax_Technologies homepage index.htm.
- Avax_Technologies industry Biomedicine.
- Avax_Technologies locationCity Philadelphia.
- Avax_Technologies locationCountry United_States.
- Avax_Technologies logo File:Avax_Logo.PNG.
- Avax_Technologies name "Avax Technologies".
- Avax_Technologies products "AC Vaccine".
- Avax_Technologies services Cancer_vaccine.
- Avax_Technologies subsid "Genopoietic SA".
- Avax_Technologies type Public_company.
- Avax_Technologies subject Category:Biotechnology_companies_of_the_United_States.
- Avax_Technologies subject Category:Companies_based_in_Pennsylvania.
- Avax_Technologies subject Category:Companies_listed_on_the_Pink_Sheets.
- Avax_Technologies subject Category:Pharmaceutical_companies_of_the_United_States.
- Avax_Technologies type Abstraction100002137.
- Avax_Technologies type BiotechnologyCompanies.
- Avax_Technologies type CompaniesBasedInPennsylvania.
- Avax_Technologies type Company108058098.
- Avax_Technologies type DrugCompany108002578.
- Avax_Technologies type Group100031264.
- Avax_Technologies type Institution108053576.
- Avax_Technologies type Organization108008335.
- Avax_Technologies type PharmaceuticalCompaniesOfTheUnitedStates.
- Avax_Technologies type SocialGroup107950920.
- Avax_Technologies type YagoLegalActor.
- Avax_Technologies type YagoLegalActorGeo.
- Avax_Technologies type YagoPermanentlyLocatedEntity.
- Avax_Technologies type Agent.
- Avax_Technologies type Company.
- Avax_Technologies type Organisation.
- Avax_Technologies type Organization.
- Avax_Technologies type Agent.
- Avax_Technologies type SocialPerson.
- Avax_Technologies type Thing.
- Avax_Technologies comment "Avax Technologies, Inc (OTC Pink: AVXT) is a Philadelphia based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007 [1]. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).".
- Avax_Technologies label "Avax Technologies".
- Avax_Technologies sameAs m.09rx4mr.
- Avax_Technologies sameAs Q4827853.
- Avax_Technologies sameAs Q4827853.
- Avax_Technologies sameAs Avax_Technologies.
- Avax_Technologies wasDerivedFrom Avax_Technologies?oldid=575318087.
- Avax_Technologies homepage www.avax-tech.com.
- Avax_Technologies homepage index.htm.
- Avax_Technologies isPrimaryTopicOf Avax_Technologies.
- Avax_Technologies name "Avax Technologies".
